Comment on F.D.A. Approves Another in a New Class of Cholesterol Drugs

F.D.A. Approves Another in a New Class of Cholesterol Drugs

The new drug, Repatha, is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.

 

Comment On This Story